HSCS (HeartSciences) Other Current Payables: $0.00 Mil (As of Jan. 2026)


HSCS HeartSciences Inc HSCS
41 GF Score
Price $2.81
GF Value $2.61
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is HeartSciences Other Current Payables?

HeartSciences HSCS -4.78% 41 Other Current Payables is $0.00 Mil as of Jan. 2026. GuruFocus rates HSCS with a GF Score™ of 41/100 and a GF Value™ of $2.61 (Fairly Valued). The stock has 7 warning signs investors should review.

HeartSciences's Other Current Payables for the quarter that ended in Jan. 2026 was $0.00 Mil.

HeartSciences Other Current Payables Related Terms

HeartSciences Other Current Payables Historical Data

* Premium members only.

The historical data trend for HeartSciences's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HeartSciences Other Current Payables Chart

HeartSciences Annual Data
Trend Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
Other Current Payables
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

HeartSciences Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
HSCS
41GF Score
HeartSciences Inc HSCS
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HeartSciences Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of $0.00 Mil mean?
HeartSciences (HSCS) has a Other Current Payables of $0.00 Mil as of Jan. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on HeartSciences and its competitors.
Is HeartSciences' Other Current Payables too high?
HeartSciences' current Other Current Payables is $0.00 Mil. Overall, HeartSciences has a GF Score™ of 41/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does HeartSciences' Other Current Payables compare to CSDX and CODX?
HeartSciences' Other Current Payables of $0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Medical Devices & Instruments company?
A good Other Current Payables depends on the Medical Devices & Instruments industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on HeartSciences and its competitors. HeartSciences's current Other Current Payables is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HeartSciences stock overvalued right now?
Based on GuruFocus' analysis, HeartSciences (HSCS) is currently considered Fairly Valued. The stock's GF Value™ is $2.61, compared to a current price of $2.81 — trading 7.7% above its estimated fair value. The current Other Current Payables is $0.00 Mil. HeartSciences' overall GF Score™ is 41/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For HeartSciences (HSCS), the current Other Current Payables is $0.00 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HeartSciences (HSCS) Overvalued in 2026?

Based on GuruFocus' analysis, HeartSciences stock appears to be overvalued. The current stock price of $2.81 is trading 7.7% above its estimated GF Value™ of $2.61. GuruFocus considers HeartSciences to be Fairly Valued.

Key valuation signals for HSCS:

  • Other Current Payables: $0.00 Mil
  • GF Value™: $2.61 vs. price of $2.81 (7.7% above fair value)
  • GF Score™: 41/100 with 7 warning signs

No single metric tells the full story. See the HSCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

HeartSciences Business Description

Address 550 Reserve Street, Suite 360, Southlake, TX, USA, 76092
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
41GF Score

Get the complete analysis for HSCS

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.81
Price
$2.61
GF Value